The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADT.L Regulatory News (ADT)

  • There is currently no data for ADT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scheme Effective

11 Apr 2023 08:17

RNS Number : 7910V
AdEPT Technology Group PLC
11 April 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

FOR IMMEDIATE RELEASE

 

11 APRIL 2023

RECOMMENDED CASH ACQUISITION

OF

ADEPT TECHNOLOGY GROUP PLC ("AdEPT")

BY

THETIS BIDCO LIMITED ("BIDCO")

a member of the Wavenet Group

 

to be effected by means of a Court-sanctioned scheme of arrangementunder Part 26 of the Companies Act 2006

Scheme Effective

 

On 8 February 2023, the boards of AdEPT and Bidco announced that they had reached agreement on the terms of a recommended all cash acquisition pursuant to which Bidco will acquire the entire issued and to be issued share capital of AdEPT (the "Acquisition"). The Acquisition is to be effected by means of a Court-sanctioned scheme of arrangement between AdEPT and relevant AdEPT Shareholders under Part 26 of the Companies Act (the "Scheme"). On 22 February 2023, AdEPT published and posted a circular in relation to the Acquisition (the "Scheme Document").

Capitalised terms used in this announcement shall, unless otherwise defined, have the meanings set out in Part Eight of the Scheme Document.

Further to the announcement made by AdEPT on 5 April 2023 that the Court had sanctioned the Scheme, AdEPT and Bidco are pleased to announce that, following the delivery of a copy of the Court Order to the Registrar of Companies earlier today, the Scheme has now become Effective and, accordingly, Bidco is now the owner of all of the Scheme Shares.

Settlement

Scheme Shareholders on the register at the Scheme Record Time, being 6.00 p.m. on 6 April 2023, will receive 201 pence in cash for each Scheme Share.

The latest date for the dispatch of cheques to Scheme Shareholders and settlement through CREST for Consideration due under the terms of the Scheme is 25 April 2023.

As a result of the Scheme having become Effective, share certificates in respect of AdEPT Shares have ceased to be valid evidence of title and entitlements to AdEPT Shares held in uncertificated form in CREST have been cancelled.

Suspension and cancellation of admission to trading on AIM

Dealings in AdEPT Shares were suspended with effect from 7.30 a.m. today. An application has been made to the London Stock Exchange for the cancellation of the admission to trading of the AdEPT Shares on AIM, which is expected to take effect from 7.00 a.m. on 12 April 2023.

Director changes

 

As envisaged in the Scheme Document, each of the Non-Executive AdEPT Directors has resigned as an AdEPT Director with effect from the Scheme becoming Effective. Each of the AdEPT Executive Directors has also resigned as an AdEPT Director with effect from the Scheme becoming Effective. Emily Wise and Venetia Cooper have been appointed as directors of AdEPT with effect from today.

 

Dealing disclosures

 

AdEPT is no longer in an "Offer Period" as defined in the Code and accordingly the dealing disclosure requirements previously notified to investors no longer apply.

 

Shareholder Helpline

If you are an AdEPT Shareholder and you have any questions relating to this announcement, please contact Computershare on 0370 889 3192. Lines are open between 8:30 a.m. and 5:30 p.m. Monday to Friday (excluding English and Welsh public holidays). Calls will be charged at the applicable national or international rates as the case may be. Different charges may apply to calls from mobile telephones. Please note that calls may be monitored or recorded and Computershare cannot provide legal, tax or financial advice or advice on the merits of the Acquisition or the Scheme.

 

Other

All references to times in this announcement are to London time.

Enquiries

AdEPT Technology Group plc

Ian Fishwick (Chairman)Phil Race (Chief Executive Officer)

 

+44 (0)34 4557 7200

Houlihan Lokey UK Limited

(Financial Adviser and Joint Rule 3 Adviser to AdEPT)James Craven

Tim Richardson

Declan O'Connor

 

+44 (0)20 7839 3355

Singer Capital Markets Advisory LLP

(Nominated Adviser, Joint Rule 3 Adviser and Broker to AdEPT) Shaun Dobson

Alaina Wong

Sandy Fraser

 

+44 (0)20 7496 3000

Belvedere Communications

(Public Relations Adviser to AdEPT) Cat Valentine

+44 (0)20 3008 6864

 

 

 

Wavenet and Bidco

Bill Dawson (Chief Executive Officer)

Venetia Cooper (Chief Financial Officer)

+44 (0)121 794 1415

 

 

Cardean Bell Ltd

(Financial Adviser to Bidco)Peter Bell

Michael Shaw

 

+44 (0)20 3982 5035

MarchHarvey Ltd

(Financial Adviser to Bidco) Oliver Levy

+44 (0)20 7289 8121

 

 

Cripps LLP is acting as legal adviser to AdEPT.

Travers Smith LLP is acting as legal adviser to Bidco.

Important notices

Houlihan Lokey UK Limited ("Houlihan Lokey"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively as financial adviser to AdEPT and for no one else in connection with the Acquisition and will not be responsible to anyone other than AdEPT for providing the protections afforded to clients of Houlihan Lokey for providing advice in relation to the Acquisition, the contents of this announcement or any other matters referred to in this announcement. Neither Houlihan Lokey nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Houlihan Lokey in connection with this announcement, any statement contained herein or otherwise.

Singer Capital Markets Advisory LLP ("Singer Capital Markets"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively as financial adviser to AdEPT and for no one else in connection with the Acquisition and will not be responsible to anyone other than AdEPT for providing the protections afforded to clients of Singer Capital Markets for providing advice in relation to the Acquisition, the contents of this announcement or any other matters referred to in this announcement. Neither Singer Capital Markets nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Singer Capital Markets in connection with this announcement, any statement contained herein or otherwise.

Cardean Bell Ltd ("Cardean Bell"), which is an Appointed Representative of Sturgeon Ventures LLP, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority ("FCA"), is acting as financial adviser to Bidco and for no one else in connection with the Acquisition and will not be responsible to anyone other than Bidco for providing the protections afforded to clients of Cardean Bell in relation to the Acquisition, the contents of this announcement or any other matters referred to in this announcement. Neither Cardean Bell nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Cardean Bell in connection with this announcement, any statement contained herein or otherwise.

MarchHarvey Ltd ("March Harvey"), which is an Appointed Representative of Kroll Securities Ltd, which is authorised and regulated in the United Kingdom by the FCA, is acting as financial adviser to Bidco and for no one else in connection with the Acquisition and will not be responsible to anyone other than Bidco for providing the protections afforded to clients of March Harvey in relation to the Acquisition, the contents of this announcement or any other matters referred to in this announcement. Neither March Harvey nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of March Harvey in connection with this announcement, any statement contained herein or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SOAGRGDSUBBDGXB
Date   Source Headline
11th Apr 202312:11 pmRNSForm 8.5 (EPT/RI)
11th Apr 20238:17 amRNSScheme Effective
11th Apr 20237:30 amRNSSuspension - AdEPT Technology Group plc
6th Apr 20233:24 pmRNSRule 2.9 Announcement
5th Apr 20232:13 pmRNSCourt Sanction of the Scheme
5th Apr 202310:42 amRNSForm 8.5 (EPT/RI)
4th Apr 20235:45 pmRNSAdEPT Technology Group
4th Apr 202311:10 amRNSForm 8.5 (EPT/RI)
3rd Apr 20239:02 amRNSForm 8.5 (EPT/RI)
31st Mar 202310:26 amRNSForm 8.5 (EPT/RI)
30th Mar 20232:17 pmRNSForm 8.3 - AdEPT Technology Group plc
30th Mar 202310:28 amRNSForm 8.5 (EPT/RI)
29th Mar 20239:05 amRNSSatisfaction of NS&I Act Condition
28th Mar 202310:25 amRNSForm 8.5 (EPT/RI)
24th Mar 202310:49 amRNSForm 8.5 (EPT/RI)
23rd Mar 202312:01 pmRNSForm 8.5 (EPT/RI)
22nd Mar 202311:46 amRNSHolding(s) in Company
22nd Mar 202310:03 amRNSForm 8.5 (EPT/RI)
22nd Mar 20239:21 amRNSForm 8.3 -AdEPT Technology Group PLC
21st Mar 20239:08 amRNSForm 8.5 (EPT/RI)
20th Mar 20232:06 pmRNSForm 8.3 - AdEPT Technology Group plc
20th Mar 202310:26 amRNSForm 8.5 (EPT/RI) - AdEPT Technology Grou
17th Mar 20232:54 pmRNSForm 8.3 - AdEPT Technology Group plc
17th Mar 20232:30 pmRNSResults of Court Meeting & General Meeting
17th Mar 202311:34 amRNSForm 8.5 (EPT/RI)
16th Mar 20233:01 pmRNSForm 8.3 - AdEPT Technology Group plc
16th Mar 20239:27 amRNSForm 8.5 (EPT/RI)
15th Mar 20232:01 pmRNSForm 8.3 - AdEPT Technology Group plc
15th Mar 20239:54 amRNSForm 8.5 (EPT/RI)
14th Mar 20239:06 amRNSForm 8.5 (EPT/RI)
13th Mar 20235:26 pmRNSUpdate to Irrevocable Undertakings
13th Mar 20233:41 pmRNSCorrection: Form 8.3 - AdEPT Technology Group plc
13th Mar 20239:52 amRNSForm 8.5 (EPT/RI)
9th Mar 202310:04 amRNSForm 8.5 (EPT/RI)
8th Mar 20232:10 pmRNSForm 8.3 - AdEPT Technology Group plc
8th Mar 20239:29 amRNSForm 8.5 (EPT/RI)
8th Mar 20238:22 amRNSForm 8.3 - AdEPT Technology Group PLC
7th Mar 20232:29 pmRNSForm 8.3 - AdEPT Technology Group plc
7th Mar 20239:44 amRNSForm 8.5 (EPT/RI)
7th Mar 20238:41 amRNSForm 8.3 - AdEPT Technology Group PLC
6th Mar 20231:36 pmRNSForm 8.3 - AdEPT Technology Group plc
6th Mar 20239:43 amRNSForm 8.5 (EPT/RI)
6th Mar 20238:27 amRNSForm 8.3 - AdEPT Technology Group PLC
3rd Mar 20232:46 pmRNSForm 8.3 - AdEPT Technology Group plc
3rd Mar 20239:21 amRNSForm 8.5 (EPT/RI)
2nd Mar 202311:11 amRNSForm 8.5 (EPT/RI)
2nd Mar 202310:03 amRNSForm 8.3 - AdEPT Technology Group PLC
1st Mar 20239:23 amRNSForm 8.5 (EPT/RI)
1st Mar 20237:00 amRNSForm 8.3 - AdEPT Technology Group plc
28th Feb 202312:53 pmRNSForm 8.3 - AdEPT Technology Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.